That would seem to set up this hearing, and a subsequent ruling which could come as early as this month, as a clear market catalyst
Free Radic Biol Med (2017) 111:31627
Additionally, pregnant or breastfeeding women should consult a healthcare provider before using semaglutide GLP-1, as its safety in pregnancy and lactation has not been fully established
That said, daily use is optional, not required
A pharmacokinetic study in growth-hormone-deficient patients using a closely related long-acting IGF-1 preparation found a terminal half-life of 5.8 hours for free IGF-1 after subcutaneous dosing, though the exact value for the research-grade LR3 analogue varies by formulation [4]
It can be a little unpredictable how someone will respond to a weight loss medication